• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing

Must-Read SEC

Investment ideas from an off-the-radar fund's latest 13F filing.
By TIM MELVIN Feb 14, 2013 | 01:30 PM EST
Stocks quotes in this article: GLW, NLY, TROX, COWN

Today is the deadline to file 13F forms with the Securities and Exchange Commission, which investment firms and hedge funds will be doing at a fast and furious pace throughout the day. The Internet and TV will be jammed with reports of who bought this and who sold out of that. The focus will be on the big firms, and there will be breathless reports on what the marquee-name fund managers -- Bill Ackman, David Einhorn, John Paulson and others -- did with their clients' assets in the final quarter of 2012. I will read all these filings because they usually contain valuable information, but I don't see any value in adding to the already noisy mix by writing about them.

But there are a few filings worth mentioning that no one else is following as these funds are not super famous and do not go out of their way to court publicity. They have racked up market-beating returns and generated very profitable ideas for me over the years. The newest addition to the list of must-read filings is one I discovered just last year, thanks to an article in Barron's. Paul Isaac of Arbiter Partners is not only the nephew of investing icon Walter Schloss, his father was an arbitrageur who once worked with value investor and fund manager Max Heine. Isaac has racked up returns of around 20% since founding the fund, outperforming the broader market and most investment managers by a very wide margin.

It has often been said that the surest sign of a man's intelligence is that he agrees with you. If this is indeed the case, then Isaac is brilliant. Among his new positions and add-on buys this quarter are some of my favorite stocks. He also has decent positions in the types of small banks that make up my Trade of the Decade.

One of Isaac's new buys in the last three months of 2012 was one of my favorite long-term stocks. Corning (GLW) has seen its stock price improve somewhat in the past few weeks, but the stock is still very cheap given the long-term potential of this company. Its glass products are used in smartphones, consumer electronics, medical and biotechnology research and environmental-emissions-control products. I have no doubt that this stock will be a growth leader and Wall Street darling in the next decade, but for now it is out of favor and cheap. At 10x earnings and less than 90% of tangible book value, this stock is a buy and should be owned my most, if not all, long-term value investors.

Isaac's fund also opened a stake in Annaly Capital (NLY), the giant mortgage real estate investment trust. Annaly is not my biggest mortgage REIT, but I do own a little bit of the stock and expect to own it for a long time. There has been a lot of bearish chatter on mortgage REITs and lengthy treatises on why they will blow up over the next few years due to interest rate movement. Perhaps the cynics will be proven correct, but in addition to smart investors like Arbiter Partners, insiders have been buying heavily across the sector. The president of Annaly, Kevin Keyes, picked up 100,000 shares in November and executives have been exercising options and holding the shares for most of the last year.

Another favorite that the fund bought in the final quarter of 2012 is pigment manufacturer Tronox (TROX). Isaac also increased a stake in Cowen Group (COWN), the brokerage, asset-management and investment-banking firm that I have owned as a long shot for a while. He was also a buyer of the Capital One (COF-WT) warrants previously mentioned in my discussion with the folks at PL Capital. To see the rest of the buying activity in Isaac's fund, I highly suggest you read the filing.

Before moving on, it is worth noting that unlike most value types, Paul Isaac takes strong short positions in stocks that he finds overvalued. At year's end, he was short Salesforce.com (CRM), Barclays (BCS), Cliffs Natural Resources (CLF) and the Australian dollar via the CurrencyShares Australian Dollar Trust (FXA). The fund also closed its short position in Apple (AAPL) at what one suspects was an enormous profit for its investors.

Given his pedigree and results, Paul Isaac is on my short list of must-follow investors that are off the radar screen of the media and most pundits.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Melvin was long GLW, NLY, TROX and COWN.

TAGS: Investing | U.S. Equity

More from Investing

Price Targets: How They Mislead and How They Can be Used

James "Rev Shark" DePorre
Jan 23, 2021 10:00 AM EST

The main problem with price targets is that they are a static number in a dynamic situation.

Stock Market Continues to Defy Conventional Wisdom

James "Rev Shark" DePorre
Jan 22, 2021 5:04 PM EST

Concerns about the action being overheated remain, but rotational action keeps the momentum going.

AMC Is a High Risk, High Reward Play

Timothy Collins
Jan 22, 2021 2:15 PM EST

Short and sweet: This is based on the high running emotions of the markets. There's little to it beyond that.

GoodRx Needs a Shot in the Arm to Improve Its Outlook

Bruce Kamich
Jan 22, 2021 2:03 PM EST

IPOs in recent months have done extremely well -- not so GDRX.

2021 and 2022 Look Difficult for Intel, While 2023 -- Might -- Be Better

Eric Jhonsa
Jan 22, 2021 1:44 PM EST

Competition from AMD and ARM CPU developers looks set to take a toll over the next two years. But Intel could be in better shape in 2023 if its new CEO is ready to make some tough choices.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 11:01 AM EST JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    I discuss price targets in my Saturday column.
  • 07:54 AM EST GARY BERMAN

    Friday Morning Fibocall for 1/22/2021

    SPX (Long-Term View) The 1/21/21 NEW high @ 3861...
  • 11:16 AM EST CHRIS VERSACE

    Worst Stocks to Buy for the Biden Presidency

    Biden's take on the minimum wage, likely moves on ...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2021 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login